Previous close | 882.60 |
Open | 890.40 |
Bid | 883.20 x 0 |
Ask | 883.20 x 0 |
Day's range | 881.60 - 894.60 |
52-week range | 504.40 - 932.00 |
Volume | |
Avg. volume | 2,643,997 |
Market cap | 3.935T |
Beta (5Y monthly) | 0.19 |
PE ratio (TTM) | 44.45 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 12.80 (1.45%) |
Ex-dividend date | 22 Mar 2024 |
1y target est | N/A |
Eli Lilly stock broke out, but then slumped. The FDA is soon to hold a meeting to discuss its Alzheimer's drug. Is LLY stock a buy or a sell?
The company will collaborate with a biotech founded by Flagship Pioneering, the venture capital firm that created Moderna.
According to the average brokerage recommendation (ABR), one should invest in Novo Nordisk (NVO). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?